Brief: Adaptive Biotechnologies Q2 EPS USD -0.31
01/08/2024 21:05
Aug 01 (Reuters) - Adaptive Biotechnologies Q2 revenue USD 43.19 million vs. IBES estimate USD 38.7 million. * Q2 operating expenses USD 90.508 million * Q2 net income USD -46.248 million vs. IBES estimate USD -48 million * Q2 operating income USD -47.318 million vs. IBES estimate USD -45.6 million * Q2 adjusted EBITDA USD -21.4 million vs. IBES estimate USD -29.9 million
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates